CONCALLS
https://t.me/+DyGeqpxOwkdlODk1 LIVE & QUARTER-WISE EARNINGS CONCALL HIGHLIGHTS 1,200+ COMPANIES COVERED #Q4FY26 | #Q1FY27 — Easy Quarter-wise Identification NO ADVERTISEMENTS NO UNRELATED CONTENT PURELY CONCALL HIGHLIGHTS
نمایش بیشتر📈 تحلیل کانال تلگرام CONCALLS
کانال CONCALLS (@concalls3) در بخش زبانی انگلیسی بازیگری فعال است. در حال حاضر جامعه شامل 10 132 مشترک است و جایگاه 11 559 را در دسته اقتصاد و امور مالی و رتبه 37 601 را در منطقه الهند دارد.
📊 شاخصهای مخاطب و پویایی
از زمان ایجاد در невідомо، پروژه رشد سریعی داشته و 10 132 مشترک جذب کرده است.
بر اساس آخرین دادهها در تاریخ 10 سپتامبر, 2026، کانال فعالیت پایداری دارد. در ۳۰ روز گذشته تغییر اعضا برابر 305 و در ۲۴ ساعت گذشته برابر 8 بوده و همچنان دسترسی گستردهای حفظ شده است.
- وضعیت تأیید: تأیید نشده
- نرخ تعامل (ER): میانگین تعامل مخاطب 17.13% است و در ۲۴ ساعت نخست پس از انتشار، محتوا معمولاً 10.64% واکنش نسبت به کل مشترکان کسب میکند.
- دسترسی پستها: هر پست به طور میانگین 1 734 بازدید دریافت میکند. در اولین روز معمولاً 1 077 بازدید جمعآوری میشود.
- واکنشها و تعامل: مخاطبان بهطور فعال حمایت میکنند؛ میانگین واکنش به هر پست 4 است.
- علایق موضوعی: محتوا بر موضوعات کلیدی مانند margin, fy26, revenue, expansion, guidance تمرکز دارد.
📝 توضیح و سیاست محتوایی
نویسنده این فضا را محل بیان دیدگاههای شخصی توصیف میکند:
“https://t.me/+DyGeqpxOwkdlODk1
LIVE & QUARTER-WISE EARNINGS CONCALL HIGHLIGHTS
1,200+ COMPANIES COVERED
#Q4FY26 | #Q1FY27 — Easy Quarter-wise Identification
NO ADVERTISEMENTS
NO UNRELATED CONTENT
PURELY CONCALL HIGHLIGHTS”
به لطف بهروزرسانیهای پرتکرار (آخرین داده در تاریخ 11 سپتامبر, 2026)، کانال همواره بهروز و دارای دسترسی بالاست. تحلیلها نشان میدهد مخاطبان بهطور فعال با محتوا تعامل دارند و آن را به نقطه اثرگذاری مهم در دسته اقتصاد و امور مالی تبدیل کردهاند.
در حال بارگیری داده...
| تاریخ | رشد مشترکین | اشارات | کانالها | |
| 11 سپتامبر | +4 | |||
| 10 سپتامبر | +8 | |||
| 09 سپتامبر | +10 | |||
| 08 سپتامبر | 0 | |||
| 07 سپتامبر | +1 | |||
| 06 سپتامبر | +2 | |||
| 05 سپتامبر | +10 | |||
| 04 سپتامبر | +3 | |||
| 03 سپتامبر | +3 | |||
| 02 سپتامبر | +5 | |||
| 01 سپتامبر | 0 |
| 2 | Latest addition to PF
Sugslloyd
Guided for 600 cr for fy 27
And 1000 crore revenue for fy28
Margins going to be maintained or improved.
Got SCADA orders from railway.
Also claims
Company claims to have 50 percent market share in FPI
( Fault passage indicator)
If company delivers we are looking 44 plus EPS. | 218 |
| 3 | KNACK PACKAGING | CONCALL UPDATES — THE STORY IS GETTING INTERESTING 💡
🔹 40%+ revenue growth
🔹 53% EBITDA growth
🔹 48% PAT growth
But the bigger story may be what is happening underneath the numbers.
FINANCIAL PERFORMANCE
• Q1 FY27 Revenue: ₹264.8 Cr | +40.5% YoY
• Volume: 10,940 MT | +20.9%
• EBITDA: ₹59.2 Cr | +53.1%
• EBITDA Margin: 22.35%
• PAT: ₹30.5 Cr | +48%
• PAT Margin: 11.53%
The key point is that EBITDA is growing faster than revenue, while revenue is growing much faster than volumes — indicating operating leverage, better product mix and cost optimisation.
EBITDA/KG — KEY METRIC TO WATCH
EBITDA/kg has improved significantly:
FY24: ~₹33/kg → FY26: ~₹45/kg → Q1 FY27: ~₹54/kg
Key drivers include:
→ Higher value-added products
→ Pinch-bottom bags
→ Operating leverage
→ Solar/energy savings
→ Cost optimisation
Management has not provided numerical forward EBITDA/kg guidance, making this an important metric to track every quarter.
PINCH-BOTTOM PREMIUMISATION
Pinch-bottom penetration has steadily increased:
FY23: ~10% → FY24: ~16% → FY25: ~20% → Current: ~22–23%
Pinch-bottom bags offer:
• 6-side branding
• Better shelf visibility
• Laser-cut/easy-open features
• Better stacking
• Tamper/security options
• Limited number of suppliers
Knack has added 2 machines specifically for this segment, indicating a clear focus on increasing the higher-value-added product mix.
CUSTOMER STICKINESS
Knack has:
• 2,000+ customers
• 13,493 SKUs
• 74 countries
• 93.75% customer continuity
Top 10 customers account for 40.87% of FY26 revenue.
The competitive advantage is not just the bag, but the combination of customisation, print quality, brand consistency, reliability and customer-specific SKUs.
Once a brand is established on packaging, changing suppliers may not be easy.
CARGILL — A GOOD EXAMPLE OF THE BUSINESS MODEL
Cargill relationship:
→ Communication started in 2017
→ Onboarded in 2020
→ Now 600+ SKUs
→ Serving 8+ countries
→ Contract-based pricing
Pricing is essentially:
Raw material/polymer cost + conversion cost
When polymer prices move, the raw-material component moves accordingly while Knack retains its conversion economics.
Management also indicated that packaging is <1% of the customer's finished-product cost in many cases.
This makes supplier reliability and consistency more important than saving a few cents on packaging.
CAPACITY — CURRENT CONSTRAINT
Current effective capacity: 48,000+ TPA
Utilisation: ~90–92%
Order book: ~₹130 Cr
To bridge the gap before the new plant becomes operational, Knack has added ~5,040 TPA rented capacity.
This allows the company to monetise current demand instead of waiting for the new facility.
NEW CAPACITY / CAPEX
IPO proceeds are being deployed into a new manufacturing facility.
Current capacity: ~48K TPA
Post new plant: ~70K TPA
Target commissioning: October 2027
Construction has started and machinery finalisation is underway.
If execution remains on track, the new facility should provide a substantial capacity runway beyond the current 90%+ utilisation levels.
EXPORT + MEXICO OPPORTUNITY 🌎
Exports accounted for 56.3% of FY26 revenue.
Knack is present across 74 countries and is targeting further growth in Europe, Australia, Gulf and Africa, while aiming to onboard more global brands.
More importantly, the 50:50 Sayem Knack JV in Mexico was commissioned in April 2026.
This provides an additional manufacturing footprint closer to North American markets.
KEY TAKEAWAY
What makes Knack interesting is not simply the 40% revenue growth.
The broader story combines:
Volume growth + Pinch-bottom premiumisation + Export growth + High utilisation + Operating leverage + Raw-material pass-through + Solar savings + Mexico JV + 70K TPA capacity
The historical margin trajectory is also encouraging:
EBITDA Margin:
15.38% FY24 → 19.31% FY25 → 20.42% FY26 → 22.35% Q1 FY27
The key question now is whether this margin expansion and earnings growth represent a structural improvement or simply a very strong phase.
The next 4–6 quarters should provide greater clarity.
No recommendations. Please do your own studies. 📝 | 493 |
| 4 | RAYMOND LTD | GROWTH DRIVERS
🚀 Aerospace Growth
- ₹510 Cr Gudipalli aerospace facility under construction across 45 acres near Bengaluru Airport.
- Commercial production targeted for late 2027.
- Facility could add ₹150–200 Cr revenue by FY29.
- Existing aerospace facility has ₹600 Cr capacity.
- Aerospace order book stands at ₹5,960+ Cr, excluding new-facility orders.
📈 Strong Aerospace Order Visibility
- 10-year order book: ₹5,960+ Cr.
- 5-year order book increased 17% sequentially to ₹2,765 Cr.
- Active RFQ pipeline of ₹1,632 Cr across 2,000+ drawings.
- Order book typically represents 2.5–3x revenue, providing multi-year visibility.
- Supports management's 25% growth commitment.
⚡ Aerospace Production Ramp-Up
- Q1 FY27 aerospace revenue grew 40% YoY to ₹123 Cr.
- Added 100+ new SKUs in FY26.
- More than one new part produced per day.
- Q1 margin stood at 21.2%, impacted by R&D costs.
- Mature EBITDA margin target of ~25%.
🚗 Auto Margin Expansion
- Q1 FY27 auto revenue grew 11% to ₹444 Cr.
- EBITDA increased 46% to ₹61 Cr.
- EBITDA margin improved to 13.8% from 10.6%.
- Growth driven by export ramp-up and operating leverage.
- Management targets 15%+ annual margins.
- Around 60% of auto business is export-driven.
🔋 Hybrid & EV Growth
- ~15% of auto revenue now comes from hybrid and EV.
- Hybrid is growing faster than EV in Europe.
- Raymond has captured major share in hybrid transmissions.
- Critical components are being horizontally deployed across customers.
- New nominations from a leading European advanced-drivetrain company add another growth opportunity.
🏭 Andhra Auto Greenfield
- New ₹430 Cr automotive component facility at Gudipalli across 32 acres.
- Commercial production targeted for late FY27/FY28.
- Existing capacity is already at 85–90% utilisation.
- Expansion will support new EV, hybrid and next-generation mobility nominations.
🛠️ Automotive Aftermarket
- Commercial rollout scheduled for Q2 FY27.
- Leverages the 70-year JK Files brand and existing distribution network.
- Uses existing OEM-grade manufacturing capacity.
- Provides a capital-efficient new revenue stream without requiring significant new capacity.
💰 Warrant-Funded Acquisitions
- Board approved ₹330.88 Cr preferential warrants to the promoter group.
- 75% earmarked for acquisitions across aerospace, automotive and defence.
- Remaining funds support capacity expansion at subsidiaries.
- Creates funding capacity for inorganic growth without significant balance-sheet strain.
🛡️ Defence Value-Chain Upgrade
- Won its maiden build-to-spec defence order from a leading defence aerospace OEM.
- Raymond completely designed the specialised onboard storage systems.
- Design certification has been received.
- Moves the company from build-to-print toward integrated Tier-1.5 partner status.
- Potentially opens a slower but higher-margin defence opportunity.
🏥 Medical Components Opportunity
- Received certification for titanium and stainless-steel medical components.
- Opens a new regulated segment adjacent to its existing precision-machining capabilities.
- Importantly, the opportunity requires no incremental capex.
KEY TAKEAWAY
- Raymond's growth story is increasingly being driven by aerospace + advanced automotive + EV/hybrid + defence + medical components.
- The biggest near-to-medium-term drivers are the ₹5,960+ Cr aerospace order book, new aerospace capacity, auto margin expansion, EV/hybrid nominations and ₹430 Cr auto greenfield.
- The company is also moving up the value chain, particularly in defence and specialised aerospace components. | 1 743 |
| 5 | RAYMOND LTD | GROWTH DRIVERS
🚀 Aerospace Growth
- ₹510 Cr Gudipalli aerospace facility under construction across 45 acres near Bengaluru Airport.
- Commercial production targeted for late 2027.
- Facility could add ₹150–200 Cr revenue by FY29.
- Existing aerospace facility has ₹600 Cr capacity.
- Aerospace order book stands at ₹5,960+ Cr, excluding new-facility orders. 0
📈 Strong Aerospace Order Visibility
- 10-year order book: ₹5,960+ Cr.
- 5-year order book increased 17% sequentially to ₹2,765 Cr.
- Active RFQ pipeline of ₹1,632 Cr across 2,000+ drawings.
- Order book typically represents 2.5–3x revenue, providing multi-year visibility.
- Supports management's 25% growth commitment. 1
⚡ Aerospace Production Ramp-Up
- Q1 FY27 aerospace revenue grew 40% YoY to ₹123 Cr.
- Added 100+ new SKUs in FY26.
- More than one new part produced per day.
- Q1 margin stood at 21.2%, impacted by R&D costs.
- Mature EBITDA margin target of ~25%. 2
🚗 Auto Margin Expansion
- Q1 FY27 auto revenue grew 11% to ₹444 Cr.
- EBITDA increased 46% to ₹61 Cr.
- EBITDA margin improved to 13.8% from 10.6%.
- Growth driven by export ramp-up and operating leverage.
- Management targets 15%+ annual margins.
- Around 60% of auto business is export-driven. 3
🔋 Hybrid & EV Growth
- ~15% of auto revenue now comes from hybrid and EV.
- Hybrid is growing faster than EV in Europe.
- Raymond has captured major share in hybrid transmissions.
- Critical components are being horizontally deployed across customers.
- New nominations from a leading European advanced-drivetrain company add another growth opportunity. 4
🏭 Andhra Auto Greenfield
- New ₹430 Cr automotive component facility at Gudipalli across 32 acres.
- Commercial production targeted for late FY27/FY28.
- Existing capacity is already at 85–90% utilisation.
- Expansion will support new EV, hybrid and next-generation mobility nominations. 5
🛠️ Automotive Aftermarket
- Commercial rollout scheduled for Q2 FY27.
- Leverages the 70-year JK Files brand and existing distribution network.
- Uses existing OEM-grade manufacturing capacity.
- Provides a capital-efficient new revenue stream without requiring significant new capacity. 6
💰 Warrant-Funded Acquisitions
- Board approved ₹330.88 Cr preferential warrants to the promoter group.
- 75% earmarked for acquisitions across aerospace, automotive and defence.
- Remaining funds support capacity expansion at subsidiaries.
- Creates funding capacity for inorganic growth without significant balance-sheet strain. 7
🛡️ Defence Value-Chain Upgrade
- Won its maiden build-to-spec defence order from a leading defence aerospace OEM.
- Raymond completely designed the specialised onboard storage systems.
- Design certification has been received.
- Moves the company from build-to-print toward integrated Tier-1.5 partner status.
- Potentially opens a slower but higher-margin defence opportunity. 8
🏥 Medical Components Opportunity
- Received certification for titanium and stainless-steel medical components.
- Opens a new regulated segment adjacent to its existing precision-machining capabilities.
- Importantly, the opportunity requires no incremental capex. 9
KEY TAKEAWAY
- | 1 |
| 6 | Your attitude is the paintbrush for your day.
Always choose colors of hope, strength and joy. | 1 039 |
| 7 | Milky Mist took 17 years to add 41000 visicoolers
Now wants to add 50000+ visicoolers in 3 years
Varun Beverages and Reliance are also getting aggressive in adding Visi coolers
Value-added dairy products and beverage theme is in capacity and distribution expansion mode!
Src – Q1FY27 call, no reco | 1 716 |
| 8 | SHERA ENERGY | FROM COPPER SCRAP TO 765kV POWER-LINE CONDUCTORS
BUSINESS OVERVIEW
- Shera Energy manufactures copper, aluminium, brass and nickel-based conductors and components used across power, electrical, industrial, automotive, solar and other applications.
- The company is moving beyond basic wire manufacturing toward a vertically integrated metals platform.
- Product portfolio ranges from basic conductors to high-value precision products used in transformers and solar modules.
- Its products effectively form part of the “nervous system” of the electricity grid.
KEY PRODUCTS
- Copper Products: Insulated/enamelled copper wires, paper-covered wires, copper bars, tubes and rods.
- Aluminium Products: Aluminium wires and conductors used in transformer windings, solar inverters and appliances.
- Brass & Nickel Products: Brass rods/tubes and specialised nickel alloys for industrial and high-temperature applications.
- Premium Products:
- CTC conductors
- Super-fine enamel wires
- Bunched strips
- Solar PV ribbons
- Premium products are used in applications including 765kV transformers and next-generation solar modules.
FINANCIAL PERFORMANCE
- Q1 FY27 Revenue: ₹**487.77 cr**, up 26% YoY and a record quarterly level.
- Q1 FY27 EBITDA: ₹**30.91 cr**, up 57% YoY.
- Q1 FY27 PAT: ₹**12.64 cr**, up 79% YoY.
- FY26 Revenue: ₹**1,640.05 cr.
- FY26 EBITDA: ₹**94.21 cr.
- FY26 PAT: ₹**37.14 cr.
- Profit is currently growing faster than revenue, indicating improving operating leverage/margins.
FY27 GROWTH GUIDANCE
- FY27 Revenue expectation: ~₹**2,100 cr**.
- FY27 PAT expectation: ~₹**55 cr**, based on management guidance.
- This implies continued growth from the ₹1,640 cr FY26 revenue base.
BACKWARD INTEGRATION | ZAMBIA COPPER CATHODES
- Subsidiary Shera Zambia is developing a copper cathode plant in Zambia’s Copperbelt Province.
- Initial capacity: 1,200 MT/year.
- Planned scale-up: 5,000 MT/year.
- The plant is designed to produce 99.99% pure copper cathodes.
- Copper is one of Shera’s largest input costs, making backward integration strategically important.
- Producing copper internally can provide greater control over raw-material sourcing, supply security and potentially input economics.
FORWARD INTEGRATION | PREMIUM CONDUCTORS
- The company is simultaneously moving toward higher-value, specialised products.
- Focus areas include:
- CTC conductors for large/high-voltage transformers.
- Super-fine enamel wires.
- Solar PV ribbons.
- Bunched strips and other precision conductors.
- These products are more specialised than commodity wires and can potentially generate better margins and stronger customer stickiness.
CAPACITY UTILISATION
- Capacity utilisation improved from 74% in FY25 to 78% in FY26.
- Higher utilisation allows fixed manufacturing costs to be spread across greater production volumes.
- Continued utilisation improvement can provide operating leverage and margin expansion.
RECYCLING & RAW-MATERIAL ADVANTAGE
- Sister company Rajputana Industries operates in scrap-metal recycling.
- Recycling capability can help reduce dependence on externally sourced raw materials.
- Creates another layer of raw-material optimisation and vertical integration.
END-MARKET EXPOSURE
- Power transmission & distribution
- Transformers
- Electric motors
- Switchgear
- Data centres
- Solar power
- Solar inverters
- Electrical appliances
- Industrial equipment
- Automotive and specialised engineering applications
- Aerospace-related high-temperature applications through nickel-based products.
BALANCE SHEET
- Tangible net worth: ₹**248.18 cr**.
- Debt-to-equity: 1.35x.
- The company is pursuing capacity expansion and vertical integration while operating with meaningful leverage, making execution and capital efficiency important monitorables.
CORE GROWTH CATALYSTS
- Zambia copper cathode plant creates a backward-integration opportunity.
- CTC conductors and premium wires provide a shift toward higher-value products.
- 765kV transformer applications offer exposure to high-voltage grid-capex growth.
- Solar PV ribbons provide exposure to India's expanding solar manufacturing ecosystem.
- Rising capacity utilisation can improve operating leverage.
- Rajputana Industries recycling can support raw-material efficiency.
- Strong Q1 FY27 performance, with PAT growth of 79% YoY, indicates improving profitability.
KEY TAKEAWAY
- Shera Energy is attempting a two-sided vertical integration strategy:
Copper cathodes → Copper/Aluminium processing → Precision conductors → Power/Transformer/Solar applications
- The key transformation is from a conventional wire manufacturer toward a globally integrated metals and specialised-conductor platform.
- The combination of backward integration into copper + forward integration into premium products + rising utilisation provides the core growth thesis.
- FY27 guidance of approximately ₹2,100 cr revenue and ₹55 cr PAT, alongside 79% YoY Q1 PAT growth, points to a potentially strong earnings-growth phase if the new capacities and premium products scale successfully. | 3 637 |
| 9 | RATNAVEER PRECISION ENGINEERING | Growth Catalysts
🚀 Copper Clad Laminate (CCL) Greenfield
- First of 5 production lines targeted for commissioning by November 2026.
- Machine expected in India by July–August 2026.
- Civil work progressing rapidly.
- At full scale by FY31:
- Revenue: ₹750+ Cr.
- EBITDA: ₹150 Cr.
- EBITDA margin: 20%.
- Potential to more than double current group EBITDA.
💰 ₹330 Cr Rights Issue
- Board approved ₹330 Cr rights issue in June 2026.
- Proceeds earmarked for:
- CCL project.
- Working capital.
- Supports equity funding requirement for CCL.
- Project benefits from ~50% government subsidy.
- Debt carries an effective interest cost of around 2%.
🏭 Existing Stainless Steel Business
- Revenue target: ₹1,800 Cr over next 3 years.
- Current revenue base: ~₹1,100 Cr.
- Management targets 25% CAGR.
- FY26 production volumes grew 29% YoY.
- FY26 production reached 46,668 MT.
- Fastener business now has 3,500+ SKUs.
- In-house nuts & bolts manufacturing supports vertical expansion.
📈 Fastener & Precision Components
- Fastener vertical continues to scale.
- 3,500+ SKUs provide broader product coverage.
- In-house manufacturing increases value addition.
- Ongoing greenfield capex supports legacy business growth.
🌏 CCL Import Substitution
- More than 90% of India's CCL is imported.
- Significant domestic import-substitution opportunity.
- Soft confirmations received from PCB manufacturers.
- Some customers are ready to buy the entire first-line output.
- Local buyers receive a 2% cash subsidy for domestic CCL purchases.
🏛 Government Subsidy Support
- CCL project approved under Electronics Component Manufacturing Scheme.
- 25% central government subsidy.
- Additional 25% Gujarat state subsidy under GEP scheme.
- Combined support covers roughly 50% of capex.
- Subsidy can be claimed progressively as lines are completed.
- Disbursement expected within 3–6 months of submission.
🇪🇺 European Precision Components Acquisition
- European precision-components target under evaluation.
- Target has approximately 66% gross margin.
- High local production costs currently compress net margin to ~3%.
- Commercial understanding completed.
- Due diligence underway.
- Acquisition expected to close in 10–12 months.
- Potential access to Fortune 500 automobile customers.
💧 Strong Liquidity
- Promoters converted 34.31 lakh warrants in May 2026.
- Conversion brought in ₹41 Cr.
- Around ₹150 Cr unutilised QIP proceeds available as of March 2026.
- Provides liquidity ahead of the rights issue.
- Supports CCL project funding and working capital.
🎯 Key Management Targets
- Existing business revenue: ₹1,800 Cr in ~3 years.
- Legacy business CAGR: 25%.
- CCL FY31 revenue potential: ₹750+ Cr.
- CCL FY31 EBITDA potential: ₹150 Cr.
- CCL EBITDA margin: 20%.
- First CCL line commissioning: November 2026.
- European acquisition timeline: 10–12 months.
✅ Key Long-Term Growth Drivers
- CCL greenfield commissioning.
- ₹750+ Cr CCL revenue opportunity.
- 20% CCL EBITDA margin.
- Massive CCL import-substitution opportunity.
- ~50% government subsidy support.
- ₹330 Cr rights issue funding.
- 25% CAGR in existing stainless-steel business.
- Fastener portfolio expansion.
- European precision-components acquisition.
- Access to Fortune 500 automotive customers.
- Strong liquidity for expansion. | 1 578 |
| 10 | ARTEMIS MEDICARE SERVICES | Growth Catalysts
🏥 Raipur Greenfield Ramp-Up
- Artemis Shanti Hospital started OPD on July 9, 2026.
- Operating theatres and cath lab live from July 27.
- PET-CT and radiotherapy expected by end-August.
- FY27 revenue target: ₹80–85 Cr.
- Expected operating loss: ₹18–20 Cr in FY27.
- Break-even targeted in 15–18 months.
- Adds 300 beds to the existing ~544 operational beds.
- Marks first expansion beyond North India.
🏨 VIMHANS South Delhi Expansion
- 650-bed hospital in Nehru Nagar.
- Operated under a 15-year Medical Services Agreement.
- Agreement extendable by another 15 years.
- 200 additional beds added to initial 450-bed plan.
- Capex: ₹75–80 lakh per bed.
- Significantly below South Delhi market rate of ₹1.75–2 Cr per bed.
- Asset-light expansion with no land purchase cost.
- Targets underserved, high-ARPOB catchment.
🏗 Gurugram Tower IV
- Board-approved 200+ bed quaternary tower.
- Focused on pediatric and women's health.
- Expected operational timeline: 18–22 months.
- Capex: ₹55 lakh per bed.
- Management expects 50% utilisation within six months.
- Break-even targeted in 8–10 months.
- Gurugram capacity expected to reach ~950 beds.
💰 ₹700 Cr QIP Fundraise
- Shareholders approved ₹700 Cr QIP.
- Fundraise timing expected in 6–8 months.
- Proceeds earmarked for new brownfield assets.
- Focus on assets near EBITDA break-even.
- Enables inorganic expansion beyond three announced projects.
- At least one additional project is being finalised.
- Deposits for new projects cannot be funded through debt.
🌍 International Patient Growth
- International patients contributed ~27% of Q1 FY27 revenue.
- Growth achieved despite the West Asian war.
- Q2 international revenue share expected closer to 30%.
- Management targets maintaining or exceeding 30% revenue share.
- Plans to add 2–3 new countries annually.
- Medical visa turnaround reduced to 7–10 days.
- Government promotion of medical tourism supports growth.
❤️ Heart-Lung Transplant Programme
- Partnership launched with KIMS Hyderabad.
- First two transplants completed within ~2 months.
- Programme has a long waiting list.
- Domestic ticket size: ₹35–55 lakh.
- International patient ticket sizes are higher.
- Adds high-acuity, high-margin revenue.
- Strengthens Gurugram flagship's advanced-care offering.
🏥 Gurugram In-Situ Bed Additions
- ~100 additional beds can be added on existing plinths.
- Current quarterly occupancy around 70%.
- Capex: ₹70–75 lakh per bed.
- Path to 800–900 beds within 1–1.5 years.
- Expansion avoids new land purchase.
- No major new construction risk.
- Funding planned through internal accruals.
🌴 Mauritius O&M Expansion
- Artemis Cascavelle Hospital has 110 beds.
- Operations started in April.
- Structured as a monthly fee-for-expertise contract.
- No P&L operating exposure for Artemis.
- Management plans two additional operations contracts.
- Asset-light recurring fee opportunity.
- Expected to add ~1% of P&L revenue.
- Requires zero capex.
📈 Asset-Light Expansion
- VIMHANS provides large bed capacity without land purchase.
- Mauritius O&M contracts require zero capex.
- Gurugram in-situ beds leverage existing infrastructure.
- New brownfield assets targeted near EBITDA break-even.
- Multiple expansion routes reduce dependence on heavy upfront investment.
🚀 Capacity Expansion
- Raipur adds 300 beds.
- VIMHANS South Delhi adds 650 beds.
- Gurugram Tower IV adds 200+ beds.
- Gurugram in-situ expansion adds ~100 beds.
- Significant capacity addition across multiple geographies.
- Expansion broadens Artemis beyond its existing North India footprint.
🎯 Key Growth Catalysts
- Raipur greenfield ramp-up.
- VIMHANS South Delhi asset-light expansion.
- Gurugram Tower IV commissioning.
- ₹700 Cr QIP-funded brownfield expansion.
- International patient share reaching/maintaining 30%+.
- Heart-lung transplant programme.
- Gurugram in-situ bed additions.
- Mauritius O&M contract expansion.
- High-ARPOB and high-acuity services.
- Asset-light expansion supporting scalable growth.
⚠️ Key Management Targets
- Raipur FY27 revenue: ₹80–85 Cr.
- Raipur break-even: 15–18 months.
- Gurugram Tower IV: 50% utilisation in six months.
- Tower IV break-even: 8–10 months.
- International revenue share: 30% or better.
- New countries: 2–3 annually.
- QIP size: ₹700 Cr.
- Gurugram capacity potential: 800–900 beds through in-situ additions. | 4 131 |
| 11 | NOVARTIS INDIA | GROWTH CATALYSTS
CHRYS CAPITAL CONSORTIUM ACQUISITION
- ChrysCapital-led consortium signed an SPA on 19 February 2026 to acquire Novartis AG’s 70.68% promoter stake for ~₹1,445.89 cr.
- Concurrent 26% mandatory open offer at ₹860.64/share.
- New promoters bring a 26-year Indian pharma track record, including Intas and Eris, potentially providing greater strategic agility and growth focus.
TRANSPLANT PORTFOLIO
- Transplant portfolio grew 14% in FY25 despite Simulect® supply constraints.
- Resolution of supply constraints can remove the key bottleneck and support continued double-digit growth in FY26-27.
- High-margin, hospital-driven therapy area provides attractive growth potential.
VOVERAN® PAIN FRANCHISE
- Voveran® portfolio delivered 6% internal growth.
- Voveran® SR recorded 102% evolution index, while Voveran® AQ injections supported 10% portfolio growth over FY23-24.
- Strong injection uptake reflects successful hospital-focused initiatives and provides scope for further growth through wider formulary access.
DR. REDDY'S DISTRIBUTION ARRANGEMENT
- Exclusive sales and distribution agreement with Dr. Reddy’s for Voveran®, Calcium and Methergine® entered its third year in FY25.
- Wider geographic distribution can improve territory coverage and prescription reach.
- Expansion through an established network can support growth with limited incremental fixed-cost investment, improving operating leverage.
EXELON® PATCH
- Exelon® Patch is contributing to portfolio growth in neurosciences.
- Differentiated transdermal Alzheimer's treatment offers convenience and safety advantages.
- Limited branded transdermal competition creates an attractive niche revenue opportunity.
DELHI VAT REFUND
- Delhi High Court admitted the company’s writ petition challenging ₹10.89 cr DVAT demand + ₹6.85 cr penalty for AY 2013-14.
- Favourable outcome could result in a ₹54.45 lakh refund.
- One-time cash benefit with limited downside as the pre-deposit is already fully provided for.
KEY TAKEAWAY
- New promoter ownership + transplant recovery + Voveran® momentum + expanding Dr. Reddy’s distribution + Exelon® growth provide multiple potential growth levers.
- The key structural catalyst is the ChrysCapital-led ownership change, which could bring greater strategic flexibility and sharper focus on the Indian pharma opportunity. | 1 122 |
| 12 | HY-TECH ENGINEERS | SMALL BASE, LONG GROWTH RUNWAY
BUSINESS OVERVIEW
- Specialised manufacturer of hydraulic fittings including DIN Metric, JIC, ORFS, conversion and customised fittings.
- Offers 11,000+ SKUs and added 880 new SKUs in FY26.
- Serves construction, agriculture, automotive, injection moulding, railways, defence and other hydraulic applications.
- In-house forging facility provides backward integration.
FINANCIAL TRACK RECORD
- Revenue: ₹141 Cr → ₹189 Cr (FY24 → FY26)
- PAT: ₹11.6 Cr → ₹22.6 Cr
- FY26 EBITDA margin: ~24%
- PAT margin: ~12%
- ROE: ~20%
- ROCE: ~24%
- D/E: ~0.24×
- Profit growth has outpaced revenue growth, indicating potential operating leverage as the business scales.
CAPACITY RUNWAY
- Current hydraulic-fitting capacity: 483 lakh pieces/year.
- Existing utilisation:
- Shirwal: 70.83%
- Kavathe: 60.42%
- Pithampur-I: 84.62%
- Pithampur-II: 68.33%
- Thane: 68.57%
- Expansion planned at Shirwal, Kavathe and Pithampur-I.
- Additional capacity: 187.2 lakh pieces/year.
- Post-expansion capacity: ~670 lakh pieces/year — ~39% increase.
- Key growth chain: Capacity → Utilisation → Revenue → Earnings.
FY27–FY28 REVENUE FRAMEWORK
- FY26A: ₹189 Cr
- FY27E: ₹215–230 Cr | Base case ~₹222 Cr
- FY28E: ₹250–275 Cr | Base case ~₹263 Cr
- These are estimates, not management guidance, and assume gradual capacity ramp-up and improving utilisation.
EXPORT OPPORTUNITY
- Exports were ~29% of FY26 revenue.
- USA alone contributed ~21%.
- Management/promoters have indicated an ambition to take exports toward ~50% over 1–2 years.
- Successful execution could materially expand the company's addressable market.
VALVES — FUTURE OPTIONALITY
- Company is evaluating diversification into hydraulic valves through organic and inorganic routes.
- Valves serve several of the same end markets as the existing fittings business.
- Potential evolution: Fittings → Valves → Broader Hydraulic Components Platform.
- No valuation credit should be given to future valve revenue until execution is demonstrated.
DEFENCE & RAILWAYS
- DRDO approval for supply of DIN hydraulic fittings used in defence projects.
- IRIS certification for hydraulic fittings specific to railway requirements.
- Qualifications are already in place; the opportunity is now to scale revenue from these sectors.
PEER LANDSCAPE
- Aeroflex Industries: Closest peer; FY26 revenue ~₹442 Cr, EBITDA margin ~23%, PAT ~₹55 Cr.
- Yuken India: Pumps, valves, cylinders and hydraulic systems; FY26 revenue ~₹462 Cr, EBITDA margin ~12%, PAT ~₹14 Cr.
- Dynamatic Technologies: Much larger and diversified across hydraulics, aerospace and automotive; FY26 revenue ~₹1,621 Cr.
- Hy-Tech's profitability profile is already comparable to Aeroflex despite its much smaller revenue base.
VALUATION
- Around ₹77–78/share:
- Market cap: ~₹737 Cr
- FY26 P/E: ~30–31×
- Valuation already reflects part of the company's profitability and growth potential.
- Key question: Can earnings grow into the valuation?
KEY RISKS
- Capacity commissioning delays
- Slow utilisation ramp-up
- Customer concentration
- Raw-material volatility
- Cyclicality
- Export execution
- Valve diversification execution
- Margin compression
- Valuation de-rating if growth disappoints
KEY TAKEAWAY
- Hy-Tech combines a small revenue base + high margins + capacity runway + export opportunity + defence/railway approvals + product diversification.
- The real thesis is whether the company can convert its ~39% capacity expansion and higher exports into sustained earnings growth.
- If execution remains strong, the Hy-Tech of FY29 could look materially different from FY26.
More Fundamental must JOIN
@Fundamental3 | 919 |
| 13 | EACH DAY OF THIS NEW MONTH
is a gift from God.
Let's live it with faith and gratitude. | 1 275 |
| 14 | Astra Micro is talking about doing 6-7 times the revenue in next 5 years | 3 556 |
| 15 | BEHARI LAL ENGINEERING LTD – Q1 FY27 CONCALL HIGHLIGHTS
#Q1FY27
Q1FY27 Performance
- Revenue from operations stood at ₹151.7 Cr, up 18% YoY; volume increased 13.4% YoY to 22,095 tonnes.
- EBITDA rose 23% YoY to ₹29.7 Cr, with margin at 19.6%; operating EBITDA margin was 18.2%.
- PAT increased 24.5% YoY to ₹19.2 Cr, with PAT margin at 12.7%.
- EBITDA/tonne increased to ~₹13,500 vs ~₹12,400 YoY.
High-Value Product Strategy
- High-value products contributed 60.4% of revenue, up from 55.7% YoY and 57.8% in FY26.
- FY26 high-value mix had already increased from 45% in FY25 to 58%.
- Management is targeting ~70% high-value product mix in the near future.
- Alloy steel contributed 47.7%, metal rolls 25.8%, engineering castings 19.8% and forging ingots 1.9% of Q1 revenue.
- Growth strategy is focused on mix improvement and realization, rather than chasing commodity volumes.
Capacity & Utilization
- Overall capacity utilization reached 90.5% in Q1; melt shop at 94% and rolling mills at 87.5%.
- The same melt shop can manufacture rolls, specialty bars and castings, allowing production to shift toward stronger/high-value demand.
- Current year growth will primarily come from product-mix optimization; additional melting capacity is expected from the next financial year.
- Unit 3 is under construction and expected to commence operations in Q1 FY28.
Unit 3 & New Products
- Unit 3 will focus on centrifugal casting, metal rolls, ICTP/ICDP rolls, HSS rolls, engineering castings and other foundry products.
- ICTP/ICDP and HSS rolls are largely imported currently, creating a significant import-substitution opportunity.
- Two centrifugal casting technologies—**vertical and horizontal**—are planned, with machinery orders already placed.
- Company expects to start production next year and sees potential for significant market share.
- Forging capabilities will support higher-margin valve steel, die steel and tool steel grades.
Order Book
- Order book stood at ₹162 Cr / 13,138 tonnes as of June 30.
- Order-book realization is around ₹1.2 lakh/tonne versus Q1 revenue realization of ~₹93,000/tonne, indicating a richer mix.
- Management highlighted that the order book is skewed toward high-value products, providing visibility for the next 2 quarters.
Defense & Aerospace
- Company has started receiving orders from government PSUs including Bharat Dynamics and Nuclear Power Corporation of India, along with private-sector defense customers.
- Products are being developed for import substitution and Make in India requirements.
- Defense customer approvals involve a long prototype and qualification cycle.
- Initial prototyping revenue has started; meaningful defense revenue is targeted from FY28.
- Management sees strong long-term opportunity in specialized grades currently not manufactured domestically.
Foundry & Power Opportunity
- Strong demand is emerging from the power sector, with customers providing order visibility extending to 2035.
- Company recently produced a 22–23 tonne single-piece casting for a major power-sector customer.
- Investments in CNC machining, testing, NDT, shot blasting, painting and finishing will provide one-stop foundry solutions.
- Forward integration should improve customer stickiness and support higher-value castings.
Financial Strength & IPO
- June-end net worth stood at ₹325 Cr, gross borrowing at only ₹11 Cr, cash at ₹52 Cr and debt/equity at 0.03x.
- ROE was 23.6% and ROCE 27%.
- IPO raised ₹301 Cr, including ₹93 Cr fresh capital; promoter holding post issue is 70.84%.
- IPO proceeds include ₹56 Cr for equipment/civil work, ~₹7 Cr for rooftop solar, debt repayment and corporate purposes.
- Company targets ~₹80 Cr CapEx in FY27, of which ₹5 Cr was spent in Q1 and ₹75 Cr is planned over the remaining quarters.
Margins & Outlook
- Gross margin improved to 48.9%, up 146 bps YoY, driven primarily by richer product mix.
- Management expects operating EBITDA margin to improve by 20–25% over the next 2–3 years from current levels.
- Solar investment should reduce power costs, while new grades, machining and forging should further increase value addition.
- Export revenue was ₹8.6 Cr in Q1 vs ₹11.5 Cr YoY; decline was attributed to shipment timing/order phasing, with no change in long-term export trend.
- Long-term growth is expected from higher-value products, Unit 3, import substitution, defense, power and exports.
KEY TAKEAWAY
- 60% high-value mix today, targeting 70% + Unit 3 from FY28. | 1 672 |
| 16 | MOLBIO DIAGNOSTICS LTD – Q1 FY27 CONCALL HIGHLIGHTS
#Q1FY27
Q1FY27 Performance
- Consolidated revenue from operations stood at ₹408 Cr.
- Sold 164 devices and 62.4 lakh test kits during Q1.
- Export revenue was ₹67 Cr, contributing 16% of total revenue.
- EBITDA stood at ₹104 Cr, with 25% EBITDA margin; PAT was ₹52.7 Cr.
- Management targets FY27 revenue growth of around 25% and EBITDA margin of 24–25%.
TruNat Platform
- 12,500 machines installed across 90+ countries, with 43 assays covering 30 diseases.
- Platform has conducted 5–6 Mn+ tests historically and generates recurring revenue through proprietary consumables.
- Around 75% of revenue currently comes from test kits.
- Early installations from 2017–18 are still running, with no device replacement cycle seen so far.
- TruNat is a closed proprietary system; third-party consumables cannot be used.
- Same machine can test multiple diseases; consumables change according to the test.
TB Opportunity
- India has around 25,000–30,000 TB diagnostic centres, while TruNat has reached only around 8,000–9,000.
- Remaining centres largely use traditional microscopy, creating a long runway for molecular diagnostic conversion.
- TruNat is one of only 2 WHO-endorsed molecular TB technologies, and the only one that is battery-operated and deployable at point-of-care.
- Newly completed government TB tender provides a 2-year contract.
- Management sees significant further opportunity in both India and international TB programs.
HPV Opportunity
- TruNat HPV underwent extensive validation led by AIIMS with support from WHO/Gates-linked agencies and was found to meet international criteria.
- Government of India has recommended rollout under the national program and found the test cost-effective.
- WHO prequalification application is also being pursued for international expansion.
- Management expects greater clarity on deployment and volumes next quarter.
Exports & Global Expansion
- Export business began around 2023 and is still in the network-building/ramp-up phase.
- Distributor network spans 90 countries, with registrations continuing across markets.
- Europe is opening through stringent IVDR/IBDR certifications, including TruNat CT-NG for chlamydia and gonorrhea.
- Management expects exports to become an important growth driver over the coming years.
- Developed-market expansion includes Europe and the US through TruNat, Prognosis and OptraScan.
Manufacturing & CapEx
- Test-kit capacity utilization is around 58%, while device capacity utilization is around 42%.
- Of the ₹200 Cr IPO proceeds, around ₹72 Cr is earmarked for automation.
- Automation should improve efficiency and enable the company to potentially double revenue from FY26 levels without major capacity expansion.
- Around ₹105 Cr will be invested in an integrated R&D centre in Bangalore.
- No major additional CapEx is currently envisaged.
R&D & Innovation
- R&D spending is maintained at around 5–6% of revenue.
- Company has 153+ scientists and 207+ patents.
- Bulk of future R&D investment will shift toward new diagnostic platforms, rather than only adding assays to TruNat.
- Focus includes both infectious and non-communicable diseases.
- Management estimates the addressable opportunity for future NCD point-of-care platforms could be 10x+ the current molecular-testing opportunity.
Prognosis
- Prognosis contributed around ₹11 Cr revenue in Q1.
- FY26 revenue was ₹154 Cr, with around ₹12 Cr PAT.
- Management expects FY27 EBITDA margin to remain around 19%, broadly similar to FY26.
- Ultra-portable X-ray products can complement TruNat for TB screening + confirmatory testing.
- Veterinary applications, particularly companion animals, are another potential growth avenue.
OptraScan
- OptraScan received US FDA clearance in July 2026 for its end-to-end digital pathology workflow covering hardware, software and AI.
- US represents around 60% of the global pathology market; discussions with large US laboratory/hospital chains are underway.
- India already has around 35–40 installations.
- OptraScan received ~$30 Mn fresh capital and is fully funded for the next 2–3 years.
- FY27 is expected to remain muted; meaningful contribution is expected from FY28–FY29 onward.
Business Outlook
- Management cautions against judging performance quarter-to-quarter as public-health business can be non-linear.
- Growth will be driven by higher machine installations, recurring kit consumption, new assays, exports and new platforms.
- Existing TB opportunity remains substantial, while HPV, hepatitis and international markets provide additional growth avenues.
KEY TAKEAWAY
- 25% growth target + 75% recurring kit revenue + strong global runway. | 1 247 |
| 17 | SHIPROCKET LTD – Q1 FY27 CONCALL HIGHLIGHTS
#Q1FY27
Q1FY27 Performance
- Transactions grew 36% YoY, GMV 31%, and revenue 34% to ₹592 Cr.
- Merchant count increased 14% while ARPU grew 18%.
- Adjusted EBITDA rose 9x to ₹8.9 Cr; loss before tax improved to ₹13.7 Cr from ₹18 Cr.
- TTM transactions stood at 216 Mn, GMV at ₹34,600 Cr and merchants at 2.24 lakh+.
Core Business
- Core revenue grew 22% YoY to ₹411 Cr, while transactions grew 31%.
- Core adjusted EBITDA stood at ₹52.7 Cr, with margin improving 50 bps YoY to 12.8%.
- Larger D2C merchants performed strongly, supporting retention, growth and mix.
- Input-cost compression from logistics partners also supported margins.
- Core EBITDA margin has improved from 6% to ~12% over the last 3 years.
Emerging Business
- Emerging revenue grew 70% YoY to ₹182 Cr, contributing 30% of revenue vs 24% last year.
- Omnichannel grew 92%, driven by quick commerce, cargo and PTL/fulfillment.
- Cross-border business declined marginally due to global volatility; focus remains on higher-margin, profitable customers.
- Martech is growing rapidly from a small base and carries better margins.
- Emerging contribution margin improved from around 9–10% to 15%, while adjusted EBITDA improved from -38% to ~-24%.
Merchant Growth & Cross-Sell
- TTM merchant base reached 2.24 lakh+.
- Emerging merchants increased from 30,000 to 48,000 YoY.
- Core merchants buying emerging services increased from 7.3% to 8.8%.
- Growth is increasingly driven by merchants buying more products across the Shiprocket stack.
- Management continues to focus on expanding the merchant funnel, which can later graduate into higher-value/power merchants.
Unit Economics
- Adjusted EBITDA per transaction improved from ₹0.22 to ₹1.5 YoY.
- Management highlighted that every incremental transaction is margin accretive after overheads.
- Contribution margin is growing faster than revenue, supported by emerging-business growth and operating leverage.
- Larger merchants generally generate lower shipping realization due to volume-based pricing, but can consume more services across the platform.
Martech Opportunity
- Martech includes checkout, conversion tools, advertising and AI-led merchant solutions.
- New QuickPay simplifies checkout by surfacing preferred payment options and discounts, helping conversion and prepaid mix.
- Steel Deal recommends complementary products and aims to increase AOV and attach rates.
- AI Assist handles pre-order queries and post-order support while enabling checkout directly inside chat.
- AI Ads can generate creatives within minutes and uses Shiprocket's commerce and purchase data for personalization.
- Martech is also being extended across Instagram, Facebook and WhatsApp to improve traffic and ROAS.
Omnichannel & Quick Commerce
- Shiprocket's system connects D2C brands with quick-commerce platforms, automating order notifications, truck allocation and delivery-slot booking.
- The platform aggregates purchase orders across multiple D2C brands and improves visibility of inventory movement.
- Management sees strong opportunity as D2C brands increasingly leverage the rapid growth of quick commerce.
Technology & Data Moat
- Shiprocket operates an asset-light model and integrates with 250+ partners and 42 courier partners.
- Platform has processed over 700 Mn transactions historically.
- More than a decade of consumer, merchant and logistics data supports routing, checkout, fraud detection and marketing decisions.
- Around 93% of checkouts have addresses filled automatically.
- Integrated data across shipping, checkout, marketing and consumer behaviour is positioned as a key competitive advantage.
Customer Acquisition
- Core CAC increased to around ₹3,600 in Q1 from ₹2,800 in the previous quarter.
- Management views CAC movement as experimental rather than seasonal.
- CAC is generally recovered within a short period through customer contribution margins.
- Company does not expect CAC to move structurally higher and continues testing new digital acquisition channels.
Competition & Retention
- Shiprocket continues to integrate with leading logistics partners rather than owning logistics assets.
- Its value proposition is access to multiple courier networks, intelligent routing, data-driven recommendations and lower RTOs.
- Larger merchants benefit from multi-carrier routing and SLA optimization, while smaller merchants gain access to capabilities they could not build independently.
- Management continues to see opportunities for cross-selling more services into the existing merchant base.
Business Model & Monetization
- Shiprocket acts as an end-to-end commerce infrastructure platform for SMEs and D2C merchants.
- Revenue is monetized on a consumption-based model, linked to shipments and checkout transactions.
- Strategy is to acquire/enable the merchant transaction first and then monetize the same order across multiple margin pools.
- Management prioritizes transaction growth over maximizing monetization of every individual service immediately.
Seasonality
- Q3 is typically the weakest quarter because larger D2C merchants redirect inventory and marketing toward marketplaces during the e-commerce festive season.
- Other than this shift, management does not see significant seasonality in the business.
KEY TAKEAWAY
- 34% revenue growth + 70% emerging growth + improving unit economics. | 840 |
| 18 | DHOOT TRANSMISSION LTD – Q1 FY27 CONCALL HIGHLIGHTS
#Q1FY27
Q1FY27 Performance
- Revenue growth was nearly 50% YoY, significantly ahead of industry growth.
- Wiring harness revenue grew 44.6% YoY while non-wiring harness revenue grew 67.7% YoY.
- EV revenue increased 79% YoY, with EV contribution rising to 27% of total revenue from 24% last year.
- EBITDA margin improved 110 bps QoQ to 15%.
- Multilink acquisition contributed around 3% to overall revenue growth for the quarter.
- Finance cost declined as working-capital debt levels were optimized following the March equity infusion.
Industry & Outlook
- Domestic automotive volumes grew >20%, while exports grew >36%.
- 2-wheeler industry grew 22.8%, with EV industry growth at 93% and ICE growth at >20%.
- Electrification remains a key growth driver across both wiring and non-wiring harness businesses.
- Addition of new customers and products should support growth over the coming years.
- Management expects 25–30% growth for FY27, while noting a softer comparison for the first six months due to the GST-led growth in H2 last year.
Margin Outlook
- Most copper inflation has already been passed through to customers, although copper prices have continued to rise.
- Management maintains 15–16% EBITDA margin guidance for FY27.
- Raw-material price increases are generally passed through with around a 3-month lag.
- Further recovery in margins is expected when the commodity cycle softens.
- July and August also saw further raw-material price increases, limiting immediate margin recovery in Q2.
Multilink Acquisition
- Full integration of Multilink is expected within 3–4 months.
- Acquisition added Hero as a customer and expanded the product portfolio with fuel-level sensors and relays.
- Significant cross-selling opportunities exist as Multilink serves customers that overlap only partly with Dhoot's existing customer base.
- Management expects Multilink to deliver around 25–30% growth, with margins broadly in line with Dhoot's overall business.
- Goodwill is currently estimated at around 20–25% of acquisition price, subject to final purchase-price allocation.
Non-Wiring Harness
- Q1 revenue stood at ₹358 Cr versus ₹213 Cr YoY.
- Business growth was 67.7%, with Multilink contributing around 10–12% of this growth during its initial period.
- Non-wiring business includes battery packs, controllers, sensors and switches.
- Battery packs remain the largest contributor within the non-wiring harness segment.
EV Opportunity
- Dhoot is present across the EV powertrain, beyond just battery-pack assembly.
- Battery-pack assembly has expanded to a second major customer, with supplies already started.
- Company is also entering the EV charging business.
- Management believes EV adoption is growing faster than earlier expectations.
- Top customers view India as an export base, creating additional opportunities from EV exports.
- EV revenue contribution is expected to exceed 30–32% within the next 2–3 years.
EV Content Potential
- EV wiring-harness content is approximately 1.5x–2.5x that of an ICE vehicle.
- Higher content comes from additional HV harnesses along with other EV components.
- With a broader product basket, total content opportunity can potentially reach up to 4x versus ICE.
- Dhoot supplies products including HV/LV harnesses, cord sets, charging guns, RCDs, chargers, DC-DC converters and battery-pack assemblies.
Battery Pack Expansion
- Company currently supplies battery packs to its leading customer and has added another major customer.
- Second-customer supplies began for approximately one month in Q1.
- Dhoot plans to consolidate its position in 2-wheeler battery packs over the next 1–2 years before aggressively pursuing 3-wheeler battery packs.
- Key battery-pack components including cell holders, tap cells, busbars, wiring harnesses, pressure sensors and connector systems are manufactured in-house.
Wiring Harness Business
- Q1 wiring-harness revenue stood at ₹1,090 Cr versus ₹753 Cr YoY.
- Company is expanding capacity at Jhajjar and Hosur, with these projects expected to add around 15–20% capacity this year.
- Current utilization is maintained around 75% to ensure sufficient capacity during peak seasonal demand.
- Customers can operate at nearly 100% efficiency during the 5–6 month peak season, requiring Dhoot to maintain capacity headroom throughout the year.
Localization & Backward Integration
- Dhoot has a strong localization drive across its wiring-harness operations.
- Imported components have reduced from around 30–35% historically to ~20–25% currently.
- Remaining components are increasingly localized through backward integration.
- Dhoot Auto Components manufactures cables, connectors, terminals and other components in-house.
- The subsidiary conducts around ₹1,200 Cr of business for group companies through internal consumption.
Raw Material Exposure
- Copper accounts for approximately 22–23% of BOM cost.
- Rising copper prices remain a near-term margin pressure.
- Customer repricing generally occurs with a ~3-month lag.
- Management expects recovery once raw-material prices begin to soften.
ADAS / Ride Vision JV
- Dhoot is progressing toward a JV with Ride Vision for 2-wheeler ADAS solutions.
- Product focuses on detecting front/rear collision risks and left/right blind spots.
- Company has presented the technology to major 2-wheeler customers and received strong interest.
- Dhoot plans to initially focus on 2-wheelers, while the technology can potentially address 4-wheelers as well.
- Adoption could be driven by future Government regulations, and management wants to be ready ahead of regulatory implementation.
EV Cord Sets & Switches
- Automotive switches business remains focused on off-highway and tractor applications and is growing broadly in line with the market.
- EV cord-set business is performing strongly.
- Dhoot expects to have around 40–45% share of new Indian EV cord-set business coming for next year.
- Company participates in both LV and HV systems for electric 2-wheelers, which management said is the case for roughly 99% of relevant applications.
M&A & Capital Allocation
- M&A remains a continuous opportunity pipeline with support from Bain.
- Priority for capital deployment is JVs, technology collaborations and organic expansion, followed by M&A.
- Indian acquisitions remain the preferred route.
- Overseas acquisitions would be considered mainly where they provide strategic access to technology or specific sectors.
- Management is currently not pursuing acquisitions in passenger vehicles, although it is in an advanced stage of a JV for passenger-vehicle HV harnesses.
Balance Sheet
- Debt stood at around ₹220 Cr at June-end, after considering the Multilink acquisition and March equity infusion.
- IPO proceeds were received in August.
- Post-IPO, management expects the company to move to a net cash position.
- Indicative net cash at end-August is around ₹1,000 Cr, subject to minor variation.
KEY TAKEAWAY
- 50% growth + 27% EV mix + 25–30% FY27 growth target. | 849 |
| 19 | FORTIS HEALTHCARE LTD – Q1 FY27 CONCALL HIGHLIGHTS
#Q1FY27
Delhi High Court Order
- Delhi High Court has directed appointment of a forensic auditor with a defined scope of investigation.
- Management stated the order does not change, limit or impede Fortis' strategic or operational plans, including CapEx, bed expansion and M&A.
- Fortis will fully cooperate with the forensic exercise while its legal teams evaluate the best way forward.
Scope of Forensic Audit
- Audit covers reconstruction of the erstwhile promoter entity FHHPL and examination of share dissipation during 2016–18.
- It also covers IHH's acquisition of controlling stake in Fortis, including approvals, filings and subsequent utilisation of investment toward acquisition of healthcare assets from RHT Health Trust.
- Scope includes examination of any role of Fortis/FHL personnel in the erstwhile promoters' share transactions.
- The role of 17 banks and financial institutions in the share dissipation is also covered.
Forensic Audit Timeline
- Auditor is required to send its information questionnaire within 4 weeks.
- Parties will have 2 weeks to respond.
- Court has set a timeline of approximately 6 months for completion/reporting of the exercise.
- Management expects the audit process to conclude within the court-prescribed timeline, although it noted the adequacy of the timeline may be challenging.
Management's Position
- Fortis believes it has been in complete compliance with applicable laws.
- Management said its internal review found nothing abnormal or improper from Fortis' side.
- Based on records reviewed, management remains confident that the outcome should be in Fortis' favour.
- Management does not currently foresee any significant or material adverse impact from the audit.
IHH Commitment
- IHH reiterated that nothing changes regarding its commitment to Fortis.
- Fortis remains IHH's growth engine for its India platform.
- IHH continues to consider the potential merger of Gleneagles and Fortis at the appropriate time.
- IHH is willing to infuse capital into Fortis if required for growth.
- IHH reiterated its commitment to increase its stake to 50%+ over the longer term.
IHH Investment Clarification
- IHH stated that its investment came through a primary issuance by Fortis, following a competitive process run by independent directors.
- IHH said it did not purchase secondary shares from the erstwhile promoters or from the open market.
- IHH highlighted that the acquisition process was fair, transparent and compliant with regulatory requirements.
- The MTO was completed last year after a delay of almost 7 years.
Singh Brothers' Shareholding
- Management stated that the erstwhile promoters had pledged shares to banks.
- Banks subsequently attached and liquidated those shares in the free market.
- As a result, the Singh brothers' holding had fallen to negligible levels by February 2018.
- Subsequently, independent directors conducted a competitive process and selected IHH as the strategic partner.
- IHH infused fresh capital through preferential allotment.
RHT Transaction
- Management reiterated that the RHT transaction was undertaken for the commercial and capital requirements of Fortis.
- RHT was a listed entity in Singapore and the transaction followed applicable regulatory and disclosure requirements.
- Management stated that the purpose of the capital infusion and utilisation of funds had been publicly disclosed.
- IHH also highlighted that the transaction complied with Singapore and Indian regulatory requirements.
Share Transfer Clarification
- Management stated that Fortis had no role in the transfer of shares between the concerned parties.
- Share transfers were executed between the parties through the registrar.
- At that time, regulations did not require promoter share transfers to obtain clearance from Fortis' compliance officer.
- Management therefore stated that Fortis was not involved in or aware of those transactions.
Operations & Brand
- Management said hospital operations remain completely insulated from the legal and shareholding issues.
- Doctors, medical teams and operational leadership remain focused on patient experience and clinical services.
- Some communication with employees and stakeholders will continue to ensure transparency.
- Management does not expect the current development to materially disrupt hospital operations.
Growth & M&A Plans
- Existing brownfield expansion plans remain intact.
- Fortis continues to actively pursue M&A opportunities.
- Management stated that the legal matter does not constrain previously disclosed growth plans or other opportunities under evaluation.
- Internal accruals will primarily support ongoing growth, while IHH remains willing to provide additional capital for major requirements.
Financial Impact
- Fortis does not currently require any provisioning related to the forensic audit.
- No liability has been fixed under the court order; management described the process as a fact-finding exercise.
- Management expects the overall financial impact to be nil, apart from legal expenses.
- Legal expenditure was approximately ₹25 Cr last year and a similar amount could be budgeted this year depending on case intensity.
- The cost of the current forensic audit is to be borne by Daiichi, as specified in the court order.
Legal Strategy
- Fortis' legal teams are reviewing the court order and consulting with senior external and internal counsel.
- Management expects to determine the appropriate legal action within the next 5–10 days.
- If required, Fortis may approach the appropriate legal forum.
- Fortis currently does not plan counter-litigation against Daiichi while the matter remains sub judice.
- Management said it will consider actions necessary to protect the company's interests.
Daiichi Litigation
- Management stated that Fortis was neither a judgment debtor nor garnishee in the relevant proceedings.
- Fortis believes it has been unfairly brought into the dispute involving the erstwhile promoters.
- IHH said the prolonged litigation also delayed its ability to consolidate Fortis faster.
- IHH reiterated that it believes its investment process was compliant and transparent.
6-Month Outlook
- Management expects the forensic audit process to take around 6 months, followed by potentially a few additional months for subsequent actions.
- If the audit proceeds as ordered, management views it as the potential last stop for this line of investigation and litigation, unless something new emerges.
- IHH confirmed that Fortis' growth plans remain intact during the next 6–12 months.
- IHH can undertake permitted corporate actions within the limits of applicable law.
KEY TAKEAWAY
- Legal uncertainty remains, but Fortis' growth plans and IHH backing remain intact. | 838 |
| 20 | STERLITE TECHNOLOGIES LTD – INVESTOR DAY HIGHLIGHTS
#Q1FY27
Structural Growth Opportunity
- STL sees a major shift in optical connectivity from “connecting people” to “connecting intelligence” as AI adoption accelerates.
- AI data centers require significantly higher bandwidth, lower latency and denser optical connectivity.
- Two key growth engines are emerging: continued telecom connectivity expansion and rapidly growing AI data center / compute connectivity.
- Optical content is increasing across more infrastructure locations and within each deployment.
AI Data Center Opportunity
- AI workloads distributed across thousands of GPUs require continuous, real-time communication, making networking an integral part of the compute system.
- Fiber requirement per rack has increased sharply from ~1,000 fibers in legacy racks to ~4,000 with Hopper, ~16,000 with Blackwell and ~64,000 with Vera Rubin.
- This represents a 64x increase in fiber content per rack across a few generations.
- High-density connectivity and pre-terminated solutions will become increasingly important.
- Data-center interconnections increase rapidly with scale: 2 DCs = 1 interconnection, 4 = 6, 6 = 15 and 10 = 45.
India Data Center Opportunity
- India's data-center capacity is currently around 1.5 GW and is expected to reach 10 GW by 2030, implying ~46% CAGR.
- Growth is supported by favorable policy, including a tax holiday through 2047, and strong power availability.
- India has 4 submarine cables under commissioning and another 3 under planning.
- Leading hyperscalers are making multi-billion-dollar investments across cloud, AI and data-center infrastructure.
- STL already supplies almost all major hyperscalers globally, creating an opportunity to extend these relationships into India.
Competitive Positioning
- STL has nearly 38 years of experience across the optical connectivity value chain.
- End-to-end vertical integration covers glass → fiber → cable → connectivity solutions.
- Integration provides greater control over quality, innovation, cost and execution speed.
- STL has ~9% global optical fiber market share outside China.
- Technology portfolio includes 785+ patents and 10+ advanced manufacturing facilities across key markets.
Lakshya – FY29 Growth Ambition
- STL announced “Lakshya”, its growth roadmap for FY29.
- Revenue target of ₹20,000 Cr by FY29 versus ₹4,750 Cr in FY26, implying >4x growth in 3 years.
- Aim is to build STL into one of the largest global players in digital connectivity.
- Strategy focuses on stronger core economics, deeper customer relationships and a larger role in global digital infrastructure.
4 Key Growth Drivers
- Expanding Optical TAM: Optical is moving deeper into data centers, racks and campuses, while rising bandwidth drives a shift from copper to optical.
- Customer Co-development: Earlier engagement allows STL to participate in connectivity architecture design rather than remain a component supplier.
- Integrated Connectivity Solutions: Opportunity to provide the complete stack from fiber and cable to assemblies, connectors and systems.
- Technology-led Differentiation: Continued investment in next-generation optical technologies to stay ahead of evolving requirements.
Technology Roadmap
- Developing hollow-core fiber and multi-core fiber technologies internally.
- Building capability for 13,000-fiber-count solutions to address next-generation density requirements.
- In-house development of co-packaged optics (CPO) and near-packaged optics.
- Focus remains on lower latency, faster transmission and moving optical connectivity closer to the compute/chip level.
FY29 Financial Targets
- Revenue target: ₹20,000 Cr by FY29 vs ₹4,750 Cr in FY26.
- EBITDA margin target: 27%+ by FY29 vs 13.2% in FY26.
- This implies >1,380 bps improvement in EBITDA margin.
- Scale, richer product mix, better utilization and higher-value solutions are expected to drive margin expansion.
Order Book & Q1FY27
- Core optical business is supported by an open order book of >$2 Bn, providing strong revenue visibility.
- Q1FY27 marked a turning point with highest-ever quarterly revenue, EBITDA and PAT.
- Management highlighted a stronger operating base, healthy order book and strengthening balance sheet.
CapEx & Capacity Expansion
- STL plans to invest approximately ₹1,000 Cr annually for the next 3 financial years.
- Preform fiber and cable capacities are targeted to increase by 50%.
- New greenfield optical connectivity facility in India will address rising demand from data centers and AI infrastructure.
- Facility will focus on higher-density integrated connectivity solutions.
Innovation Investment
- Company plans to invest approximately 2% of average annual revenue in innovation.
- Key focus areas include hollow-core fiber, multi-core fiber and co-packaged optics.
- Investments are expected to support higher growth, stronger margins and better returns on capital.
Business Transformation
- STL expects the optical connectivity market to become larger, more diversified and less cyclical.
- Growth is increasingly supported by secular drivers across telecom, AI data centers and data-center interconnect.
- Customer relationships are moving from component supply toward deeper architectural partnerships.
- Integrated solutions should help STL capture a greater share of the optical connectivity value chain.
KEY TAKEAWAY
- ₹20,000 Cr revenue + 27%+ EBITDA margin by FY29, led by AI-driven optical demand. | 1 352 |
